JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB45899

Anti-MBNL1 抗体

Anti-MBNL1 antibody

4

(3 Reviews)

|

(24 Publications)

Anti-MBNL1 antibody (ab45899) is a rabbit polyclonal antibody detecting MBNL1 in Western Blot, IHC-P, ICC/IF. Suitable for Human.

- Over 10 publications
- Trusted since 2009

查看别名

EXP, KIAA0428, MBNL, MBNL1, Muscleblind-like protein 1, Triplet-expansion RNA-binding protein

4 Images
Western blot - Anti-MBNL1 antibody (AB45899)
  • WB

Project

Western blot - Anti-MBNL1 antibody (AB45899)

ab45899 recognises all three known isoforms to MBNL1

All lanes:

Western blot - Anti-MBNL1 antibody (ab45899) at 1 µg/mL

Lane 1:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Lane 2:

Jurkat nuclear extract lysate (<a href='/products/unavailable/jurkat-nuclear-extract-lysate-ab14844'>ab14844</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 42 kDa

Observed band size: 110 kDa,35 kDa,40 kDa,42 kDa,52 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MBNL1 antibody (AB45899)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MBNL1 antibody (AB45899)

IHC image of ab45899 staining in human skeletal muscle formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab45899, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-MBNL1 antibody (AB45899)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-MBNL1 antibody (AB45899)

ab45899 staining MBNL1 in MCF7 cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab45899 at 1µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Western blot - Anti-MBNL1 antibody (AB45899)
  • WB

CiteAb

Western blot - Anti-MBNL1 antibody (AB45899)

MBNL1 western blot using anti-MBNL1 antibody ab45899. Publication image and figure legend from García-Puga, M., Saenz-Antoñanzas, A., et al., 2020, Aging (Albany NY), PubMed 32310829.

ab45899 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab45899 please see the product overview.

DM1-derived fibroblasts present impaired metabolism. (A) Kinetic normalized OCR response in DM1 and control fibroblasts in basal conditions and after consecutive addition of Oligomycin 1.5 μM, FCCP 1.5 μM and Antimycin-A/Rotenone 1.5 μM. A representative experiment out of 3 is shown with 3 independent control cultures and 2 DM1. (B, C) Quantification of mitochondrial respiratory functions and coupling efficiency in DM1 (n=7) and control fibroblasts (n=3). (D) Representative energy map and (E) Quantification of metabolic potential of DM1 and control fibroblasts. Stressed indicates the values of OCR and ECAR after the injection of oligomycin and FCCP simultaneously. Results are obtained from controls (n=3) and DM1 (n=5) cultures. (F) Representative immunoblots of phospho-AKT, AKT, DMPK and MBNL1 in DM1-derived fibroblasts and healthy controls (n=3).

false

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB, IHC-P, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

产品详情

What is this antibody validated in?
Anti-MBNL1 antibody (ab45899) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of MBNL1?
Anti-MBNL1 (ab45899) specifically detects a band for MBNL1 (UniProt: Q9NR56) at a molecular weight of 35,40,42kDa.

Trusted by the scientific community
Anti-MBNL1 (ab45899) was first used in a scientific publication in 2009 and has been cited over 10 times in peer-reviewed journals.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
存储溶液
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The MBNL1 protein also known as Muscleblind-like protein 1 or MBNL1 is a RNA-binding protein with a molecular mass of approximately 38 kDa. This protein has a central role in the regulation of alternative splicing. It binds to specific RNA motifs and affects the splicing of pre-mRNA. MBNL1 is expressed widely in many tissues including skeletal and cardiac muscles as well as the brain indicating its wide-ranging importance in various cellular processes.
Biological function summary

The MBNL1 protein is involved in the regulation of mRNA metabolism. It functions not just individually but often as a part of larger ribonucleic complexes impacting RNA stability and translation. MBNL1 controls the alternative splicing of numerous transcripts which is necessary for the proper development and function of tissues. Disruptions in MBNL1 activity can lead to mis-splicing of transcripts which demonstrates the key role it plays in maintaining cellular homeostasis.

Pathways

The MBNL1 protein contributes significantly to splicing regulation and muscle-specific gene expression pathways. It interacts with proteins like CELF1 which modulate pre-mRNA processing. These pathways are vital for muscle cell differentiation and maintenance with MBNL1 acting alongside other splicing factors to ensure the correct expression patterns necessary for tissue-specific functions. The balance between MBNL1 and its interacting partners influences splicing outcomes and gene expression.

The dysregulation of MBNL1 activity is implicated in myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2). In these conditions expanded CUG or CCUG repeat RNAs sequester MBNL1 disrupting its function and leading to splicing abnormalities. Through this mechanism MBNL1 connects to other proteins like CUGBP1 which also influences splicing in muscle and other tissues. The resulting mis-splicing from impaired MBNL1 activity underlies many symptoms seen in these muscular disorders highlighting the protein's clinical relevance.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. Regulates the TNNT2 exon 5 skipping through competition with U2AF2. Inhibits the formation of the spliceosome A complex on intron 4 of TNNT2 pre-mRNA. Binds to the stem-loop structure within the polypyrimidine tract of TNNT2 intron 4 during spliceosome assembly. Binds to the 5'-YGCU(U/G)Y-3'consensus sequence. Binds to the IR RNA. Binds to expanded CUG repeat RNA, which folds into a hairpin structure containing GC base pairs and bulged, unpaired U residues. Together with RNA binding proteins RBPMS and RBFOX2, activates vascular smooth muscle cells alternative splicing events (PubMed : 37548402). Regulates NCOR2 alternative splicing (By similarity).
See full target information MBNL1

文献 (24)

Recent publications for all applications. Explore the full list and refine your search

iScience 28:112890 PubMed40727942

2025

Drug delivery agent that acts as a drug for synergistic activity.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Li,Ullas V Chembazhi,Sarah B Krueger,Zachary Dewald,Junfeng Chen,Yugang Bai,Dongwook Kim,Amie N Lanzendorf,Philip A Kocheril,Jie Chen,Auinash Kalsotra,Steven C Zimmerman

Scientific reports 15:23847 PubMed40615482

2025

Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Jiang,Ji Li,Jiali Zhang,Yulei Zhao,Guoqin He,Xiaohui Yao

Nature communications 16:2158 PubMed40044661

2025

Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.

Applications

Unspecified application

Species

Unspecified reactive species

Preeti Kumari,Lauren M Sullivan,Zhaozhi Li,E Parker Conquest,Elizabeth Cornforth,Rojashree Jayakumar,Ningyan Hu,J Alexander Sizemore,Brigham B McKee,Robert R Kitchen,Paloma González-Pérez,Constance Linville,Karla Castro,Hilda Gutierrez,Soleil Samaan,Elise L Townsend,Basil T Darras,Seward B Rutkove,Susan T Iannaccone,Paula R Clemens,Araya Puwanant,Sudeshna Das,Thurman M Wheeler

Journal of neuromuscular diseases 11:981-995 PubMed39031377

2024

Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.

Applications

Unspecified application

Species

Unspecified reactive species

Marie-Pier Roussel,Aymeric Ravel-Chapuis,Jonathan Gobin,Bernard J Jasmin,Jean-Philippe Leduc-Gaudet,Cynthia Gagnon,Elise Duchesne

Biomedicines 12: PubMed38540147

2024

Circulating Exosomes from Septic Mice Activate NF-κB/MIR17HG Pathway in Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Shao-Chun Wu,Cheng-Shyuan Rau,Yi-Chan Wu,Chia-Jung Wu,Chia-Wen Tsai,Lien-Hung Huang,Chia-Wei Lin,Tsu-Hsiang Lu,Ming-Yu Yang,Ching-Hua Hsieh

Nature communications 14:1956 PubMed37029100

2023

Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy.

Applications

Unspecified application

Species

Unspecified reactive species

Ningyan Hu,Eunjoo Kim,Layal Antoury,Thurman M Wheeler

Pharmaceutics 15: PubMed37111604

2023

BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah J Overby,Estefanía Cerro-Herreros,Jorge Espinosa-Espinosa,Irene González-Martínez,Nerea Moreno,Juan M Fernández-Costa,Jordina Balaguer-Trias,Javier Ramón-Azcón,Manuel Pérez-Alonso,Thorleif Møller,Beatriz Llamusí,Rubén Artero

iScience 26:106502 PubMed37091233

2023

Network model integrated with multi-omic data predicts MBNL1 signals that drive myofibroblast activation.

Applications

Unspecified application

Species

Unspecified reactive species

Anders R Nelson,Darrian Bugg,Jennifer Davis,Jeffrey J Saucerman

Life (Basel, Switzerland) 13: PubMed36675972

2022

RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7.

Applications

Unspecified application

Species

Unspecified reactive species

Rocío Suárez-Sánchez,Rodolfo Daniel Ávila-Avilés,J Manuel Hernández-Hernández,Daniel Sánchez-Celis,Cuauhtli N Azotla-Vilchis,Enue R Gómez-Macías,Norberto Leyva-García,Arturo Ortega,Jonathan J Magaña,Bulmaro Cisneros,Oscar Hernández-Hernández

JCI insight 7: PubMed36040809

2022

Senescence plays a role in myotonic dystrophy type 1.

Applications

Unspecified application

Species

Unspecified reactive species

Mikel García-Puga,Ander Saenz-Antoñanzas,Gorka Gerenu,Alex Arrieta-Legorburu,Roberto Fernández-Torrón,Miren Zulaica,Amets Saenz,Joseba Elizazu,Gisela Nogales-Gadea,Shahinaz M Gadalla,Marcos J Araúzo-Bravo,Adolfo López de Munain,Ander Matheu
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com